Background illustration for clinical trials search

Paid Clinical Trials Killeen

Discover 680 paid clinical trials in Killeen, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Austin TX, Dallas TX, Houston TX, Little Rock AR,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase3, Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Cancer, Prostatic Neoplasms
Location: Austin TX, San Antonio TX, Dallas TX, Tulsa OK,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT06056830

Phase3, Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Austin TX, Lafayette LA, Germantown TN, Columbia MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Austin TX, Dallas TX, Houston TX, Little Rock AR,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

for
Bladder Cancer, Urinary Bladder Neoplasms
Location: Austin TX, Myrtle Beach SC, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07222488

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PSMA PET Combined With MRI for the Detection of PCa

for
PCA, Prostate Cancer, Prostatic Neoplasm, PSMA PET,
Location: Austin TX, Lafayette LA, New Orleans LA, Germantown TN,
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited

Sex: Male

Age: 18+

Code: NCT07052214

Phase3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Austin TX, San Antonio TX, Dallas TX, Houston TX,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

for
Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP),
Location: Austin TX, Houston TX, Chapel Hill NC, Orange CA,
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18 - 70+

Code: NCT06371417

Phase1, Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

for
Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis,
Location: Austin TX, Dallas TX, Kansas City MO, St Louis MO,
Sponsor: Eidos Therapeutics, a BridgeBio company

Sex: All

Age: 18 - 70+

Code: NCT06563895

Phase3, Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Location: Austin TX, Kansas City KS, Kansas City MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05327114

Phase2, Phase3, Recruiting

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

for
Sporadic Inclusion Body Myositis (sIBM),
Location: Austin TX
Sponsor: Austin Neuromuscular Center

Sex: All

Age: 45 - 70+

Code: NCT06479863

Early_phase1, Recruiting

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

for
Myasthenia Gravis
Location: Austin TX, Kansas City KS, O'Fallon IL, Iowa City IA,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06298565

Recruiting

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

for
FSHD
Location: Austin TX, Dallas TX, Kansas City KS, Aurora CO,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 0+

Code: NCT04635891

Recruiting

Descartes-08 in Autoantibody Myositis

for
Antisynthetase Syndrome
Location: Austin TX, Chapel Hill NC, Orange CA, Boston MA
Sponsor: Cartesian Therapeutics

Sex: All

Age: 18+

Code: NCT07391605

Phase2, Recruiting

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

for
Bipolar I Disorder, Mania
Location: Austin TX, Little Rock AR, Garden Grove CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07288320

Phase2, Recruiting

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

for
Myasthenia Gravis, MG, gMG, Generalized Myasthenia Gravis,
Location: Austin TX, San Antonio TX, Chattanooga TN, Tampa FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07294170

Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Austin TX, San Antonio TX, Chattanooga TN, Tampa FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07284420

Phase2, Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

for
Generalized Myasthenia Gravis
Location: Austin TX, Philadelphia PA
Sponsor: Amgen

Sex: All

Age: 2 - 17

Code: NCT06987539

Phase2, Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

for
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP,
Location: Austin TX, Houston TX, Slidell LA, Colorado Springs CO,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07091630

Phase3, Recruiting

Study of COYA 302 for the Treatment of ALS

for
Amyotrophic Lateral Sclerosis (ALS)
Location: Austin TX, San Antonio TX, Dallas TX, Houston TX,
Sponsor: Coya Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07161999

Phase2, Phase3, Recruiting